Welcome to the University of Utah School of Medicine
The University of Utah School of Medicine combines excellence in teaching, research, and clinical expertise to train tomorrow's physicians for the rapidly changing world of medicine. With a faculty of more than 1,000 physicians and researchers and 22 clinical and basic science departments, the School of Medicine trains the majority of Utah physicians, offering:
The School of Medicine also is widely recognized for interdisciplinary research in the genetics of disease, cancer, biomedical informatics, infectious diseases, and other areas of leading-edge medicine.
Interested in learning more? Browse our student's page for information on our range of programs, eligibility, and how to apply.
Choose a category below and begin exploring our site:
New guidance from the Centers for Disease Control and Prevention (CDC) suggest COVID-19 antibody tests often are inaccurate, with accuracy of the test at 49% in some populations. According to Dr. Daniel Leung (Associate Professor, Infectious Diseases) antibody testing should really be used to inform public health policy decisions because on a larger scale the testing can be more accurate. ... Read More
An international team of researchers including University of Utah Health scientists report that they have developed the world’s smallest, fully functional version of insulin.... Read More
A team of researchers at University of Utah Health, including Drs. Sankar Swaminathan (Professor & Chief, Infectious Diseases) and Dinesh Verma (Research Assistant Professor, Infectious Diseases) have shown the Epstein-Barr virus — which causes mononucleosis and is linked to development of several cancers — uses a novel strategy to survive. ... Read More
Despite improvements in their performance over the past decade, electronic health records (EHRs) commonly used in hospitals nationwide fail to detect up to one in three potentially harmful drug interactions and other medication errors, according to scientists at University of Utah Health, Harvard University, and Brigham and Women’s Hospital in Boston.... Read More
Dr. Christos Vaklavas (Associate Professor, Oncology) appears as corresponding author for a manuscript which recently appeared in the Journal of Clinical Oncology: "Phase II Study of AZD4547 in Patients With Tumors Harboring Aberrations in the FGFR Pathway: Results From the NCI-MATCH Trial (EAY131) Subprotocol W." ... Read More
A team of researchers at University of Utah Health have shown the Epstein-Barr virus — which causes mononucleosis and is linked to development of several cancers — uses a novel strategy to survive.... Read More
